Literature DB >> 7739524

Sequential mutations in the interleukin-3 (IL3)/granulocyte-macrophage colony-stimulating factor/IL5 receptor beta-subunit genes are necessary for the complete conversion to growth autonomy mediated by a truncated beta C subunit.

J Hannemann1, T Hara, M Kawai, A Miyajima, W Ostertag, C Stocking.   

Abstract

An amino-terminally truncated beta C receptor (beta C-R) subunit of the interleukin-3 (IL3)/granulocyte-macrophage colony-stimulating factor/IL5 receptor complex mediates factor-independent and tumorigenic growth in two spontaneous mutants of a promyelocytic cell line. The constitutive activation of the JAK2 protein kinase in these mutants confirms that signaling occurs through the truncated receptor protein. Noteworthily, in addition to a 10-kb deletion in the beta C-R subunit gene encoding the truncated receptor, several secondary and independent mutations that result in the deletion or functional inactivation of the allelic beta C-R subunit and the closely related beta IL3-R subunit genes were observed in both mutants, suggesting that such mutations are necessary for the full oncogenic penetrance of the truncated beta C-R subunit. Reversion of these mutations by the expression of the wild-type beta C-R in the two mutants resulted in a fivefold decrease in cloning efficiency of the mutants in the absence of IL3, confirming a functional interaction between the wild-type and truncated proteins. Furthermore, expression of the truncated beta C-R subunit in factor-dependent myeloid cells did not immediately render the cells autonomous but increased the spontaneous frequency to factor-independent growth by 4 orders of magnitude. Implications for both leukemogenic progression and receptor-subunit interaction and signaling are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739524      PMCID: PMC230469          DOI: 10.1128/MCB.15.5.2402

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus.

Authors:  C Stocking; R Kollek; U Bergholz; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

Review 3.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

4.  Distinct classes of factor-independent mutants can be isolated after retroviral mutagenesis of a human myeloid stem cell line.

Authors:  C Stocking; U Bergholz; J Friel; K Klingler; T Wagener; C Starke; T Kitamura; A Miyajima; W Ostertag
Journal:  Growth Factors       Date:  1993       Impact factor: 2.511

5.  Autocrine stimulation after transfer of the granulocyte/macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway.

Authors:  C Laker; C Stocking; U Bergholz; N Hess; J F De Lamarter; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

6.  A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family.

Authors:  P Besmer; J E Murphy; P C George; F H Qiu; P J Bergold; L Lederman; H W Snyder; D Brodeur; E E Zuckerman; W D Hardy
Journal:  Nature       Date:  1986 Apr 3-9       Impact factor: 49.962

7.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

8.  Frequent c-fms activation by proviral insertion in mouse myeloblastic leukaemias.

Authors:  S Gisselbrecht; S Fichelson; B Sola; D Bordereaux; A Hampe; C André; F Galibert; P Tambourin
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

9.  A safe packaging line for gene transfer: separating viral genes on two different plasmids.

Authors:  D Markowitz; S Goff; A Bank
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

10.  Growth of factor-dependent hemopoietic precursor cell lines.

Authors:  T M Dexter; J Garland; D Scott; E Scolnick; D Metcalf
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  6 in total

1.  Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells.

Authors:  Christiane Stuhlmann-Laeisz; Sigrid Lang; Athena Chalaris; Paliga Krzysztof; Sudarman Enge; Jutta Eichler; Ursula Klingmüller; Michael Samuel; Matthias Ernst; Stefan Rose-John; Jürgen Scheller
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

2.  Down-regulating the expression of IL-3Rβ interfered with the proliferation, not differentiation in NB4 cells.

Authors:  Xin Li; Yong Wu; Yuanzhong Chen
Journal:  Int J Hematol       Date:  2011-01-05       Impact factor: 2.490

3.  CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma.

Authors:  Ningning Zhu; Yueyang Yang; Haitong Wang; Peng Tang; Hongdian Zhang; Haiyan Sun; Lei Gong; Zhentao Yu
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

4.  Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: findings and recommendations.

Authors:  Kevin Watanabe-Smith; Jamila Godil; Anupriya Agarwal; Cristina Tognon; Brian Druker
Journal:  Oncotarget       Date:  2017-02-21

5.  Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia.

Authors:  K Watanabe-Smith; C Tognon; J W Tyner; J P P Meijerink; B J Druker; A Agarwal
Journal:  Leukemia       Date:  2016-04-27       Impact factor: 11.528

6.  Discovery of a novel potentially transforming somatic mutation in CSF2RB gene in breast cancer.

Authors:  Mamoon Rashid; Rizwan Ali; Bader Almuzzaini; Hao Song; Alshaimaa AlHallaj; Al Abdulrahman Abdulkarim; Omar Mohamed Baz; Hajar Al Zahrani; Muhammed Mustafa Sabeena; Wardah Alharbi; Mohamed Hussein; Mohamed Boudjelal
Journal:  Cancer Med       Date:  2021-11-02       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.